| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Email: |
enquiry@leancare.co.uk |
| Products Intro: |
|
| Company Name: |
2A PharmaChem USA
|
| Tel: |
(630) 737-0988 |
| Email: |
sales@2apharmachem.com |
| Products Intro: |
|
|
| | gitaloxin Basic information |
| Product Name: | gitaloxin | | Synonyms: | gitaloxin;16-Formylgitoxin;3β-[[4-O-[4-O-(2,6-Dideoxy-β-D-ribo-hexopyranosyl)-2,6-dideoxy-β-D-ribo-hexopyranosyl]-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy]-16β-formyloxy-14-hydroxy-5β,14β-card-20(22)-enolide;[3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] formate;[3-[5-[5-(4,5-dihydroxy-6-methyl-oxan-2-yl)oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] methanoate;formic acid [3-[5-[5-(4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-hydroxy-17-(5-keto-2H-furan-3-yl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] ester;Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-16-(formyloxy)-14-hydroxy-, (3β,5β,16β)- | | CAS: | 3261-53-8 | | MF: | C42H64O15 | | MW: | 808.95 | | EINECS: | 221-864-7 | | Product Categories: | | | Mol File: | 3261-53-8.mol |  |
| | gitaloxin Chemical Properties |
| Melting point | 251.5°C | | Boiling point | 674.74°C (rough estimate) | | density | 1.1231 (rough estimate) | | refractive index | 1.5940 (estimate) |
| | gitaloxin Usage And Synthesis |
| Originator | Gitaloxin,Shanghai Lansheng Corporation | | Definition | ChEBI: A cardenolide glycoside that is gitoxin in which the 16beta-hydroxy group has been formylated. | | Manufacturing Process | 0.2 g gitoxin was dissolved in 15 ml of dimethylformamide and mixed with 2
ml of acetanhydride, 3 ml formic acid (98%) and 2 ml triethylamine or
pyridine. The reaction mixture stood for 60 min. at room temperature, then it
was diluted with water, a precipitated product was filtered off. A filtrate was
shook with chloroform 2 times. Chloroform was distilled to dryness and the
residue was added to the precipitate. 16-Formylgitoxin was isolated by
fraction crystallization. MP: 250°-253°C, yield about 50%. | | Therapeutic Function | Cardiotonic |
| | gitaloxin Preparation Products And Raw materials |
|